Innovation & Collaborations The Center for Discovery and Innovation actively partners with notable organizations such as BioVersys AG, Scynexis Inc., MIT, and Weill Cornell Medicine, highlighting opportunities to introduce advanced research tools, lab technologies, and collaborative solutions tailored for cutting-edge biomedical research.

Research Focus With recent participation in immunological symposiums and development of sophisticated transmission simulation systems, the company demonstrates a focus on infectious diseases and immune-related research, presenting prospects for labs and institutions seeking specialized simulation and diagnostic technologies.

Growth & Revenue Generating between $25 million and $50 million in annual revenue with a team of up to 200 employees, the company is an emerging player providing scalable solutions and innovations in biomedical research, suitable for upselling premium research tools, software, and collaborative platforms.

Technological Infrastructure The company's use of cloud and web technologies like Microsoft Azure, Google Analytics, and Ceros indicates an openness to adopting advanced digital solutions, creating opportunities for sales in data management, analytics, and content delivery platforms to enhance research and communication efforts.

Funding & Market Position While specific funding data is not available, the company's active research collaborations and participation in prominent scientific events suggest a strong position in the research services industry, opening opportunities for funding-related products or services that support grant management, compliance, and research commercialization.